Astellas Pharma Market Cap

Astellas Pharma has a market cap or net worth of $17.55 billion as of February 21, 2025. Its market cap has decreased by -15.58% in one year.

Market Cap

17.55B

Enterprise Value

22.47B

Revenue

11.88B

Ranking

n/a

PE Ratio

n/a

Stock Price

$9.73

Market Cap Chart

Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 17.55B, an increase of 152.11%. That is a compound annual growth rate of 2.83%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	17.55B	0.43%
Dec 30, 2024	17.48B	-18.50%
Dec 29, 2023	21.44B	-22.67%
Dec 30, 2022	27.73B	-7.87%
Dec 30, 2021	30.10B	5.02%
Dec 30, 2020	28.66B	-10.92%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.19B
SS Innovations International	1.72B
Nika Pharmaceuticals	1.02B
Veradigm	864.81M
Elite Pharmaceuticals	520.73M
Glass House Brands	497.07M
CytoDyn	367.12M
Northwest Biotherapeutics	326.95M

Market Cap Rankings